Plus Therapeutics, Inc.

PSTV · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4,423$5,151-$17,401-$3,903
Dep. & Amort.$86$121$146$103
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$152$148$128
Change in WC$1,259-$4,503-$1,438$2,373
Other Non-Cash$530-$6,719$12,373$88
Operating Cash Flow-$2,548-$5,798-$6,172-$1,211
Investing Activities
PP&E Inv.-$34-$7-$3-$11
Net Acquisitions$0$0$0$0
Inv. Purchases-$3,312$0$0-$8,445
Inv. Sales/Matur.$4,643$3,131$3,531$8,520
Other Inv. Act.$0-$7,756$30$0
Investing Cash Flow$1,297-$4,632$3,558$64
Financing Activities
Debt Repay.$1,488$0-$3,257$0
Stock Issued-$3,925$221$0$0
Stock Repurch.$220-$220$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$14,524$2,795$15,662$0
Financing Cash Flow$12,307$2,796$12,405$0
Forex Effect$0$0$0$0
Net Chg. in Cash$11,056-$7,634$9,791-$1,147
Supplemental Information
Beg. Cash$2,233$9,867$76$1,223
End Cash$13,289$2,233$9,867$76
Free Cash Flow-$2,575-$5,805-$6,175-$1,222
Plus Therapeutics, Inc. (PSTV) Financial Statements & Key Stats | AlphaPilot